Location History:
- Leymen, FR (2010)
- Basel, CH (2012)
Company Filing History:
Years Active: 2010-2012
Title: Louis Walliser: Innovator in Pharmaceutical Chemistry
Introduction
Louis Walliser is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrimidine derivatives. With a total of 2 patents, Walliser's inventions have the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Walliser's latest patents include the development of 2,4-Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors. These patents disclose pyrimidine derivatives of a specific formula, wherein R, R, R to R, and Z have particular significations as indicated in the claims. These compounds exhibit interesting pharmaceutical properties, making them valuable in the field of drug development.
Career Highlights
Throughout his career, Walliser has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug discovery.
Collaborations
Walliser has collaborated with esteemed colleagues such as Rolf Baenteli and Marie Claude Bernhard. These partnerships have fostered a collaborative environment that enhances innovation and the development of new pharmaceutical solutions.
Conclusion
Louis Walliser's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical treatments.